Latest Biology Technology from Bio-Medicine.Org

ThromboGenics - Positive Microplasmin Phase II Data Published in Ophthalmology

Tue, 09 Feb 2010 12:25:43 MST

LEUVEN, Belgium , February 9 /- - Paper Examines the Potential of Microplasmin to Improve the Treatment of a Range of Back of the Eye Diseases ThromboGenics NV (Euronext Brussels: THR), a biopharmaceutical company focused on the discovery and development of innovative treatments for eye disease, vasc...

QIAGEN Acquires Exclusive Licence for Key PI3K gene

Mon, 08 Feb 2010 04:48:00 MST

VENLO, The Netherlands , February 8 /- QIAGEN (NASDAQ: QGEN ; Frankfurt Prime Standard: QIA) today announced that its wholly owned subsidiary DxS has acquired the global and exclusive licence for biomarker PI3K from Johns Hopkins University to develop real-time-PCR and endpoint PCR assays. Research has shown that variati...

Tianyin Pharmaceutical Co., Inc. Announces Record Second Quarter 2010 Financial Results

Mon, 08 Feb 2010 04:47:56 MST

CHENGDU, China , Feb. 8 /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical Co., Inc., (NYSE Alternext: TPI), a manufacturer and supplier of modernized traditional Chinese medicine ("TCM") based in Chengdu, China , today announced fiscal results for its second quarter ended December 31, 2009 . -- Q2 2010 Revenue Increased 47.9% to $14.9 Mi...

YM BioSciences reports second quarter 2010 operational and financial results

Mon, 08 Feb 2010 04:47:49 MST

MISSISSAUGA, ON , Feb. 8 / YM BioSciences Inc. (NYSE YMI, TSX: YM), today reported operational and financial results for the second quarter of fiscal 2010, ended December 31, 2009 . "After rigorous evaluation of numerous global in-licensing opportunities, we proposed to merge Cytopia Limited., a clinical-stage, Melbourne -based drug developme...

Astrogenetix Continues MRSA Vaccine Development Onboard Endeavor

Mon, 08 Feb 2010 02:29:31 MST

Space Shuttle Endeavor lifted off from NASA’s Kennedy Space Center this morning, carrying on board the eighth scientific payload for Astrogenetix, a commercial biotech company created to use microgravity to develop the foundation of new medicines. (Vocus) February 8, 2010 -- Space Shuttle Endeavor lifted off from NASA’s Kennedy Spa...

Silicon Kinetics Announces New Biosensor Chips With Wide Palette of Surface Chemistries

Mon, 08 Feb 2010 09:49:59 MST

The world's first 3D biosensor surface for label-free biomolecular interaction analysis now offers surface chemistries for: carboxyl, streptavidin, benzaldehyde, NTA-Ni for His-tagged proteins, Protein A and Protein G for coupling antibodies. San Diego, CA (PRWEB) February 8, 2010 -- Silicon Kinetics Inc., the pioneering life sciences tool co...

China Medical Technologies to Participate Investor Conferences in March 2010

Mon, 08 Feb 2010 08:34:56 MST

BEIJING , Feb. 8 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED ), a leading China -based advanced in-vitro diagnostic ("IVD") company, today announced that it will participate at the following investor conferences in March 2010 : Investor Conference Date Location Rodman &...

Biocell Center Furthers Its Commitment to Maternal-Fetal Medicine

Mon, 08 Feb 2010 08:34:52 MST

MEDFORD, Mass. , Feb. 8 /- Biocell Center announced today its further commitment to working with maternal-fetal-medicine doctors by attending the Society for Maternal-Fetal Medicine's (SMFM) annual meeting. "Biocell Center has been working with perinatologists and Ob/Gyn doctors worldwide for several years," said Kate Torchilin , CEO of Biocell...

Corgenix and Tulane Announce Award of Additional NIH Contract to Expand Lassa Fever Research Towards Development of Vaccines and Improved Therapeutic Agents

Mon, 08 Feb 2010 08:34:47 MST

DENVER and NEW ORLEANS , Feb. 8 /- Corgenix Medical Corporation (OTC Bulletin Board: CONX), a worldwide developer and marketer of diagnostic test kits, and Tulane University , today announced a major extension of the collaborative effort to combat viral hemorrhagic fever (VHF), an effort that will generate an additional $800,000 in contract revenu...

Resverlogix Completes Patient Recruitment for ASSERT Trial

Mon, 08 Feb 2010 08:34:41 MST

Full enrollment occurs five months ahead of schedule TSX Exchange Symbol: RVX CALGARY, Feb. 8 / Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) announced today the completion of patient enrollment in the Phase 2 clinical study of its lead drug RVX-208. "The completion of enrollment for our Phase 2 ASSERT trial, a full...

MBS Value Partners Hires Two New Senior Staff Members

Mon, 08 Feb 2010 08:34:36 MST

NEW YORK , Feb. 8 /- MBS Value Partners, a strategic communications firm specializing in investor relations and corporate communications for domestic and international clients, announced today that Lisa Lettieri and Matthew Haines have joined as Managing Directors. “Lisa and Matt bring outstanding senior-level advisory and corporate experience...

ClearTrial Selected to Provide Methodologies for Accurately Forecasting and Budgeting Clinical Spend and Integrated Financial Controls at CBI Conference

Mon, 08 Feb 2010 07:27:48 MST

Two members of the ClearTrial clinical services team to present the critical processes that comprise a more accurate forecast and budget discipline across clinical development departments. Chicago, IL (PRWEB) February 8, 2010 -- ClearTrial, the leading provider of Clinical Trial Operations (CTO) software, today announced that both Kristin Luca...

Invida Selects LaVoie Group as Public Relations Agency of Record

Mon, 08 Feb 2010 07:27:44 MST

LaVoie Group, a life science-focused strategic communications agency, announced today that it has been selected by Invida Group, the leading provider of healthcare brands and services in Asia Pacific, to develop and execute its corporate communications and public relations program. Salem, MA (Vocus) February 8, 2010 -- LaVoie Group , a life s...

Neurocrine Biosciences Announces the Appointment of William H. Rastetter to Its Board of Directors

Mon, 08 Feb 2010 05:29:22 MST

SAN DIEGO , Feb. 8 /- Neurocrine Biosciences, Inc. (Nasdaq: NBIX ) announced today that it has appointed William H. Rastetter Ph.D. to its Board of Directors effective immediately. He is the current Chairman and Chief Executive Officer of Receptos, Inc., and former Executive Chairman of Biogen Idec, Inc. "We are very pleased to welcome Bill...

3SBio and Panacor Bioscience Enter Collaboration and License Agreement to Develop and Commercialize Nephoxil(R) for Hyperphosphatemia

Mon, 08 Feb 2010 05:29:02 MST

SHENYANG, China , Feb. 8 /PRNewswire-Asia-FirstCall/ -- 3SBio Inc. (Nasdaq: SSRX ) ("3SBio" or "the Company"), a leading China -based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced a collaboration and license agreement with Panacor Bioscience Ltd. to develop and commercializ...

Healthcare Data Solutions Announces Expansion of its Healthcare Customer Solutions Team With Two Key Additions

Mon, 08 Feb 2010 02:18:35 MST

Healthcare Data Solutions (HDS) is pleased to announce that it has hired Lisa Wichman and Sahar Meyer to its expanding staff of healthcare and data experts. Ms. Wichman joins HDS as an Account Manager and will focus on key healthcare markets in the Northeast. Ms. Meyer will lead the AnalyticsPRO Division as the Manager of that group Omaha, NE....

New technology detects chemical weapons in seconds

Sat, 06 Feb 2010 07:05:38 MST

Scientists at Queen's University Belfast are developing new sensors to detect chemical agents and illegal drugs which will help in the fight against the threat of terrorist attacks. The devices will use special gel pads to 'swipe' an individual or crime scene to gather a sample which is then analysed by a scanning instrument that can detect the presence of chemicals within seconds. This wi...

Despite claims, UK did not gas Iraqis in the 1920s, new research finds

Fri, 05 Feb 2010 07:20:01 MST

It has passed as fact among historians, journalists and politicians, and has been recounted everywhere from tourist guidebooks to the floor of the U.S. Congress: British forces used chemical weapons on Iraqis just after World War I. But that claim has never been fully squared with the historical record, says R. M. Douglas, a historian at Colgate University. According to Douglas's research...

Simple test could offer cheap solution to detecting landmines

Fri, 05 Feb 2010 07:19:58 MST

Scientists have developed a simple, cheap, accurate test to find undetected landmines. Students from the University of Edinburgh have created a custom-made bacteria that glows green when it comes into contact with chemicals leaked by buried explosives. The bacteria can be mixed into a colourless solution that, when sprayed on to the ground, forms green patches to indicate the presence...

New antioxidant compounds have been identified in foods such as olive oil, honey and nuts

Fri, 05 Feb 2010 07:19:55 MST

This release is available in Spanish . Scientists at the University of Granada have identified and characterized for the first time different antioxidant compounds from foods such as olive oil, honey, walnuts and a medicinal herb called Teucrium polium. They have used two new techniques, capillary electrophoresis and high resolution liquid chromatography, that have enabled them to...